SALT LAKE CITY, Nov. 4, 2009 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (Nasdaq:MYGN) announced today that Gregory C. Critchfield, M.D., President of Myriad Genetic Laboratories, Inc., is scheduled to present an overview of the Company at the Lazard Capital Markets Sixth Annual Healthcare Conference, at 9:30 a.m. Eastern on November 18, 2009, at the St. Regis Hotel in New York City.
